文献速递肝病

EAT-Lancet参考饮食与代谢功能障碍相关脂肪性肝病及其严重程度的关联:一项多队列研究

Associations of the EAT-Lancet reference diet with metabolic dysfunction-associated steatotic liver disease and its severity: A multicohort study.
PubMed 文献 · Hepatology · 2024-08-02

该前瞻性多队列研究纳入天津TCLSIH队列15263人、广州GNHS队列1137人、英国生物银行175078人,另纳入228例经活检证实的MASLD中国成人。EAT-Lancet饮食指数最高三分位者MASLD风险较低三分位者更低,且肝受控衰减参数随饮食指数升高而下降。

要点

  • EAT-Lancet饮食指数最高三分位者MASLD风险低于最低三分位者:TCLSIH HR=0.87,GNHS HR=0.79,UK Biobank HR=0.73。
  • 在经活检证实的MASLD患者中,肝受控衰减参数随饮食指数升高而下降(β=-5.895)。
  • 坚持EAT-Lancet参考饮食与MASLD风险及其严重程度呈负相关。

核心结论

  • 坚持EAT-Lancet参考饮食与MASLD风险及其严重程度呈负相关。

研究设计与样本

  • 前瞻性多队列研究,纳入TCLSIH队列15263名成人、GNHS队列1137名成人、英国生物银行175078名成人。
  • 另纳入228名经活检证实MASLD的中国成人(PERSONS研究)。
  • 构建EAT-Lancet饮食指数以反映对EAT-Lancet参考饮食的坚持程度。

主要发现

  • TCLSIH队列在53575人年随访中记录3010例MASLD,GNHS队列在6454人年随访中记录624例,英国生物银行在1745432人年随访中记录1350例。
  • 多变量模型中,EAT-Lancet饮食指数最高三分位者较低三分位者MASLD风险更低:TCLSIH HR=0.87(95%CI 0.78,0.96),GNHS HR=0.79(95%CI 0.64,0.98),英国生物银行HR=0.73(95%CI 0.63,0.85)。
  • 在经活检证实的MASLD个体中,肝受控衰减参数随饮食指数升高而下降(β=-5.895;95%CI -10.014,-1.775)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: The EAT-Lancet Commission devised a globally sustainable dietary pattern to jointly promote human health and sustainability. However, the extent to which this diet supports metabolic dysfunction-associated steatotic liver disease (MASLD) has not yet been assessed. This study aimed to investigate the association between the EAT-Lancet diet and the risk of MASLD and its severity. APPROACH AND RESULTS: This prospective multicohort study included 15,263 adults from the Tianjin Chronic Low-grade Systemic Inflammation and Health (TCLSIH) cohort, 1137 adults from the Guangzhou Nutrition and Health Study (GNHS) cohort, and 175,078 adults from the UK Biobank. In addition, 228 Chinese adults from the Prospective Epidemic Research Specifically of Non-alcoholic Steatohepatitis (PERSONS) with biopsy-proven MASLD were included. An EAT-Lancet diet index was created to reflect adherence to the EAT-Lancet reference diet. The TCLSIH cohort recorded 3010 MASLD cases during 53,575 person-years of follow-up, the GNHS cohort documented 624 MASLD cases during 6454 person-years of follow-up, and the UK Biobank developed 1350 MASLD cases during 1,745,432 person-years of follow-up. In multivariable models, participants in the highest tertiles of the EAT-Lancet diet index had a lower risk of MASLD compared with those in the lowest tertiles (TCLSIH: HR = 0.87, 95% CI: 0.78, 0.96; GNHS: HR = 0.79, 95% CI: 0.64, 0.98; UK Biobank: HR = 0.73, 95% CI: 0.63, 0.85). Moreover, liver-controlled attenuation parameter decreased with increasing the diet index in individuals with biopsy-proven MASLD (β = -5.895; 95% CI: -10.014, -1.775). CONCLUSIONS: Adherence to the EAT-Lancet reference diet was inversely associated with the risk of MASLD as well as its severity.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Zhang S, Yan Y, Zeng XF, et al. Associations of the EAT-Lancet reference diet with metabolic dysfunction-associated steatotic liver disease and its severity: A multicohort study. Hepatology. 2024. PMID: 39094016. doi:10.1097/HEP.0000000000001039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。